These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1887157)

  • 21. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
    Zic JA
    Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracorporeal photochemotherapy: a scientific overview.
    Sniecinski I
    Transfus Sci; 1994 Dec; 15(4):429-37. PubMed ID: 10155561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extracorporeal photochemotherapy: review of its mechanisms of action and clinical applications].
    Vanheste S; Vereecken P; Lambermont M; Heenen M; Bron D
    Rev Med Brux; 2007; 28(5):445-51. PubMed ID: 18069519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience.
    Jiang SB; Dietz SB; Kim M; Lim HW
    Photodermatol Photoimmunol Photomed; 1999 Oct; 15(5):161-5. PubMed ID: 10540936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photopheresis for the treatment of cutaneous T cell lymphoma.
    Armus S; Keyes B; Cahill C; Berger C; Crater D; Scarborough D; Klainer A; Bisaccia E
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):898-902. PubMed ID: 2147701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Extracorporeal photochemotherapy].
    Viguier M; Pouthier F; Tiberghien P; Aubin F
    Transfus Clin Biol; 2010 Feb; 17(1):28-33. PubMed ID: 20042357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
    Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
    J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and flow cytometry outcome of improved photopheresis methods in dermatologic patients].
    Ullrich H; Stolz W; Barlage S; Lackner KJ; Rothe G; Schmitz G
    Beitr Infusionsther Transfusionsmed; 1997; 34():256-64. PubMed ID: 9417345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal photopheresis: a review on the immunological aspects and clinical applications.
    Chiesa-Fuxench ZC; González-Chávez J
    P R Health Sci J; 2010 Dec; 29(4):337-47. PubMed ID: 21261172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the mechanism of action of extracorporeal phototherapy.
    Moss FM
    Transfusion; 2006 Jan; 46(1):6-8. PubMed ID: 16398723
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
    Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
    Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photopheresis: a new therapeutic concept.
    Edelson RL
    Yale J Biol Med; 1989; 62(6):565-77. PubMed ID: 2700056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
    Heald PW; Perez MI; Christensen I; Dobbs N; McKiernan G; Edelson R
    Yale J Biol Med; 1989; 62(6):629-38. PubMed ID: 2534648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
    Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection.
    Wolfe JT; Lessin SR; Singh AH; Rook AH
    Artif Organs; 1994 Dec; 18(12):888-97. PubMed ID: 7887825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Extracorporeal photopheresis in dermatology].
    Pérez-Carmona L; Harto-Castaño A; Díez-Recio E; Jaén-Olasolo P
    Actas Dermosifiliogr; 2009; 100(6):459-71. PubMed ID: 19709550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.